Fungal infections in children with human immunodeficiency virus infection

Seminars in Pediatric Infectious Diseases

Volumn 12, Issue 4, 2001, Pages 288-295

  Pirofski, Liise Anne ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CLOTRIMAZOLE; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; NYSTATIN;

ASPERGILLOSIS; CANDIDIASIS; CLINICAL FEATURE; COCCIDIOIDOMYCOSIS; CRYPTOCOCCOSIS; DRUG CHOICE; HISTOPLASMOSIS; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MYCOSIS; PENICILLIUM MARNEFFEI; PROGNOSIS; REVIEW; RISK FACTOR;

EID: 0034749805     PISSN: 10451870     EISSN: None     Source Type: Journal    
DOI: 10.1053/spid.2001.26636     Document Type: Article

References (48)

1. Fungal infections in patients with acquired immunodeficiency syndrome
2. Current approaches to diagnosis and treatment of fungal infections in children infected with human immuno deficiency virus
3. Aspergillus Fumigatus and Aspergillosis
4. Fungal infections in children with HIV
5. Opportunistic infections of the central nervous system in children with HIV infection: Report of 9 autopsy cases and review of the literature
6. Disseminated fungal infections in children infected with human immunodeficiency virus
7. Fungemia in children infected with the human immunodeficiency virus: New epidemiologic patterns, emerging pathogens, and improved outcome with antifungal therapy
8. Risk factors for fungemia in children infection with human immunodeficiency virus: A case-control study
9. Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection
10. Human cryptococcosis, in Cryptococcus neoformans (ed 1)
11. Epidemiologic evidence for dormant Cryptococcus neoformans infection
12. Persistence of initial infection in recurrent Cryptococcus neoformans meningitis
13. Evidence of zoonotic transmission of Cryptococcus neofomans from a pet cockatoo to an immunocompromised patient
14. Antibodies reactive with the cryptococcal capsular polysaccharide glucuronoxylomannan are present in sera from children with and without HIV infection
15. Antibodies to Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan are ubiquitous in the serum of HIV + and HIV - Individuals
16. Quantitative and qualitative differences in the serum antibody profiles of HIV-infected persons with and without Cryptococcus neoformans meningitis
17. Serologic evidence for Cryptococcus neoformans infection in early childhood
18. Analysis of human monoclonal antibodies elicited by vaccination with a Cryptococcus neoformans glucuronoxylomannan capsular polysaccharide vaccine
19. Extrapulmonary cryptococcosis in children with acquired immunodeficiency syndrome
20. Cryptococcosis in children with AIDS
21. Cryptococcosis in human immunodeficiency virus-infected children
22. Estimation of the prevalence of cryptococcal infection among patients infected with the human immunodeficiency virus in New York City
23. False-negative cerebrospinal fluid cryptococcal latex agglutination tests for patients with culture-positive cryptococcal meningitis
24. Serum cryptococcal antigen in patients with AIDS
25. Aspergillus species
26. Aspergillus pneumonia in chronic granulomatous disease: Recurrence and long term outcome
27. Impairment of neutrophil antifungal activity against hyphae of Aspergillus fumigatus in children infected with human immunodeficiency virus
28. Defective antifungal activity of monocyte-derived macrophages from human immunodeficency virus-infected children against Aspergillus fumigatus
29. Invasive aspergillosis in human immunodeficiency virus-infected children
30. New targets and delivery systems for antifungal therapy
31. Efficacy of the echinocandin capsofungin against disseminated aspergillosis and candidiasis in cyclophosphamide-induced immunosuppressed mice
32. Treatment of invasive pulmonary aspergillosis in severely neutropenic children with malignant disorders using liposomal amphotericin B (Ambisome), granulocyte colony stimulating factor and surgery: Report of five cases
33. Retrospective analysis of infectious disease in patients who received recombinant human granulocyte- macrophage colony-stimulating factor versus patients not receiving a cytokine who underwent autologous bone marrow transplantation for treatment of lymphoid cancer
34. Recombinant human interferon-gamma as adjunct therapy for Aspergillus infection in a patient with chronic granulomatous disease
35. Histoplasma capsulatum
36. Disseminated histoplasmosis of infancy
37. Disseminated histoplasmosis in children: The role of itraconazole therapy
38. Disseminated histoplasmosis as the acquired immunodeficiency syndrome-defining illness in an infant
39. Disseminated histoplasmosis in a human immunodeficiency virus-infected African child
40. The Histoplasma capsulatum antigen assay in disseminated histoplasmosis in children
41. Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome
42. Coccidioides immitis
43. Coccidioidomycosis during human immunodeficiency virus infection: Results of a prospective study in a coccioidal endemic area
44. Review of coccidiodomycosis in immunocompromised children
45. Disseminated coccidioidomycosis with chorioretinitis in early infancy
46. Disseminated Penicillium marneffei infection in Southeast Asia
47. Miscellaneous fungi and Prototheca
48. Disseminated Penicillium marneffei infection in human immunodeficiency virus-infected children